Aurobindo Pharma shares today rose over 4 per cent after the company posted a consolidated net profit of Rs 563 crore for the March quarter.
The drug maker's scrip climbed 4.32 per cent to Rs 787.05 at BSE.
On NSE, the scrip went up 4.31 per cent to Rs 787.
The firm had posted a net profit of Rs 403.8 crore in the January-March period of 2014-15 fiscal.
Net sales of the company rose to Rs 3,674.7 crore in the fourth quarter of 2015-16 fiscal. It had reported a net sales of Rs 3,143.97 crore during the same period of the previous fiscal, Aurobindo Pharma had said in a regulatory filing yesterday.
For the year ended March 31, the company posted a net profit of Rs 1,982 crore while it stood at Rs 1,575.77 crore during the 2014-15 fiscal.
Net sales of the company stood at Rs 13,650.61 crore in the 2015-16 fiscal, while it was Rs 12,043.23 crore in the preceding fiscal.
The company said results of the quarter and year ended March 31, were not comparable with those of previous year.
The company's board had approved interim dividend of 70 per cent, Re 0.70 per equity share of Re 1 each on the equity share capital of the company for the year 2015-16.
